Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study.
Dikdik KurniaGeofanny Sarah HutabaratDevi WindaryantiTati HerlinaYetty HerdiyatiMieke Hemiawati SatariPublished in: Drug design, development and therapy (2020)
Two allylpyrocatechol derivatives were predicted to have a good potency as a novel natural antibacterial agent against S. sanguinis through blocking MurA activity that causes disruption of bacterial cell wall.